Avadel Pharmaceuticals (AVDL) Short-term Investments (2016 - 2022)
Historic Short-term Investments for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $45.8 million.
- Avadel Pharmaceuticals' Short-term Investments fell 6277.37% to $45.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $45.8 million, marking a year-over-year decrease of 6277.37%. This contributed to the annual value of $106.5 million for FY2021, which is 2883.95% down from last year.
- According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Short-term Investments is $45.8 million, which was down 6277.37% from $50.0 million recorded in Q2 2022.
- Avadel Pharmaceuticals' Short-term Investments' 5-year high stood at $157.3 million during Q1 2018, with a 5-year trough of $40.0 million in Q1 2020.
- Moreover, its 5-year median value for Short-term Investments was $106.5 million (2021), whereas its average is $99.0 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Short-term Investments skyrocketed by 26471.72% in 2021 and then tumbled by 6315.94% in 2022.
- Avadel Pharmaceuticals' Short-term Investments (Quarter) stood at $90.6 million in 2018, then plummeted by 39.97% to $54.4 million in 2019, then skyrocketed by 175.23% to $149.7 million in 2020, then fell by 28.84% to $106.5 million in 2021, then plummeted by 57.04% to $45.8 million in 2022.
- Its last three reported values are $45.8 million in Q3 2022, $50.0 million for Q2 2022, and $62.6 million during Q1 2022.